Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00556465

Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy

Study of N-Acetylcysteine for Treatment of Overt Diabetic Nephropathy

Sponsor: Shiraz University of Medical Sciences

Conditions Chronic Kidney Disease Diabetes Type 2 Diabetic Nephropathy

Updated 5 times since 2017 Last updated: Nov 9, 2007 Started: Jan 31, 2007 Completion: Jun 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Chronic Kidney Disease and Diabetes Type 2, this trial is completed. The trial is conducted by Shiraz University of Medical Sciences and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shiraz University of Medical Sciences

Data source: Shiraz University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shiraz, Iran